These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 8776027

  • 1. A 16-year-old girl with epistaxis and hepatosplenomegaly.
    Woods M, Greenes D.
    Curr Opin Pediatr; 1995 Dec; 7(6):733-9. PubMed ID: 8776027
    [No Abstract] [Full Text] [Related]

  • 2. Gaucher Disease: Clinical, Biological and Therapeutic Aspects.
    Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S.
    Pathobiology; 2016 Dec; 83(1):13-23. PubMed ID: 26588331
    [Abstract] [Full Text] [Related]

  • 3. Giant lymphadenopathy infiltrated by gaucher cells mimicking lymphoma.
    Yağci B, Salor O, Yalçin B, Gürakan F, Güçer S, Büyükpamukçu M.
    Pediatr Blood Cancer; 2009 Jul; 52(7):870-1. PubMed ID: 19213078
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Gaucher disease and β-thalassemia: A rare coinheritance.
    Makis A, Tzoufi M, Pappa E, Kyrochristos I, Zikou A, Xydis V, Argyropoulou MI, Chaliasos N.
    Blood Cells Mol Dis; 2017 Jun; 65():35-37. PubMed ID: 28458077
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Analysis of the pre-retinal opacities in Gaucher Disease using spectral domain optical coherent tomography.
    Sheck LH, Wilson CJ, Vincent AL.
    Ophthalmic Genet; 2012 Dec; 33(4):253-6. PubMed ID: 22950450
    [Abstract] [Full Text] [Related]

  • 9. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI, Pastores GM, Isola L, Giraldo P, Bueno Gómez J.
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract] [Full Text] [Related]

  • 10. Recommendations on diagnosis, treatment, and monitoring for Gaucher disease.
    Martins AM, Valadares ER, Porta G, Coelho J, Semionato Filho J, Pianovski MA, Kerstenetzky MS, Montoril Mde F, Aranda PC, Pires RF, Mota RM, Bortolheiro TC, Brazilian Study Group on Gaucher Disease and other Lysosomal Storage Diseases.
    J Pediatr; 2009 Oct; 155(4 Suppl):S10-8. PubMed ID: 19765407
    [No Abstract] [Full Text] [Related]

  • 11. Gaucher disease type 1: Unexpected diagnosis in a 75-year old patient presenting with splenomegaly.
    Han M, Byun JM, Koh Y, Yoon SS, Yang D.
    Curr Probl Cancer; 2021 Dec; 45(6):100708. PubMed ID: 33583590
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The importance of correct phenotyping in Gaucher disease.
    Harris CM, Campbell P.
    J Child Neurol; 2007 Aug; 22(8):1056-7. PubMed ID: 17761664
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Gaucher disease. Current issues in diagnosis and treatment. NIH Technology Assessment Panel on Gaucher Disease.
    JAMA; 1996 Feb 21; 275(7):548-53. PubMed ID: 8606477
    [Abstract] [Full Text] [Related]

  • 19. Management of neuronopathic Gaucher disease: a European consensus.
    Vellodi A, Bembi B, de Villemeur TB, Collin-Histed T, Erikson A, Mengel E, Rolfs A, Tylki-Szymanska A, Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease.
    J Inherit Metab Dis; 2001 Jun 21; 24(3):319-27. PubMed ID: 11486896
    [No Abstract] [Full Text] [Related]

  • 20. A 2-year-old girl with failure to thrive, progressive hepatosplenomegaly and progressive encephalopathy.
    Hung PL, Chang YC, Huang LT, Lui CC, Lin JW, Huang SC.
    Acta Paediatr Taiwan; 2003 Jun 21; 44(1):1-3. PubMed ID: 12800374
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.